Global Parasitic Diseases Therapeutics Market 2019-2023

The global parasitic diseases therapeutics market size will grow by USD 1.79 billion during 2019-2023. The parasitic diseases therapeutics market report provides a detailed analysis of the market by type (antiprotozoal therapeutics, anthelminthic therapeutics, and scabicides and pediculicides therapeutics) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Pfizer Inc., Sanaria Inc.

Some of the key findings from our parasitic diseases therapeutics market forecast report are summarized below

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the parasitic diseases therapeutics​ report.

Get a FREE sample now!

Global Parasitic Diseases Therapeutics Industry Overview

The high mortality and morbidity of protozoal and helminthic parasitic diseases have increased the adoption of prophylactic treatment. Preventive chemotherapy is used to control the transmission of helminthic infections within a community. The high prevalence of malaria across the world has also driven researchers to develop various vaccines to prevent the spread of the disease. Researchers are also developing several prophylactic vaccines to control and avoid cutaneous leishmaniasis and visceral leishmaniasis. The increasing adoption of such prophylactic vaccines to prevent and control parasitic diseases will be one of the critical parasitic diseases therapeutics market trends, which will have a positive impact on the growth of the market.

The prevalence of parasitic infections caused by protozoa, helminths, and ectoparasites is increasing. The number of people infected by whipworms and hookworms is rising every year. The number of reported cases of African trypanosomiasis, especially in countries of sub-Saharan Africa such as Zambia, Tanzania, Uganda, and Malawi has also increased significantly. Similarly, the prevalence of Chagas disease is high in parts of Central America, South America, and Mexico. Moreover, the prevalence of schistosomiasis is also increasing worldwide. The rising incidence of such parasitic infections will result in an increasing demand for parasitic disease therapeutics. This will be a significant factor fueling the growth of the market at a CAGR of about 5% during the forecast period.

Top Parasitic Diseases Therapeutics Companies Covered in this Market Research Report

The global parasitic diseases therapeutics market is fragmented. To help clients improve their market position, the parasitic diseases therapeutics market report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this parasitic diseases therapeutics market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.

The report offers a detailed analysis of several leading parasitic diseases therapeutics companies, including:

• Bayer AG
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Pfizer Inc.
• Sanaria Inc.

Parasitic Diseases Therapeutics Market Segmentation Based on Type

• Antiprotozoal therapeutics
• Anthelminthic therapeutics
• Scabicides and pediculicides therapeutics

The antiprotozoal therapeutics segment will account for the highest parasitic diseases therapeutics market share. The high prevalence of parasitic diseases and the development, approval, and availability of drugs for the treatment of protozoal infections are expected to boost parasitic diseases therapeutics market growth in this segment. The parasitic diseases therapeutics market report provides an accurate prediction of the contribution of all the segments to the growth of the parasitic diseases therapeutics market size.

Parasitic Diseases Therapeutics Market Segmentation Based on Geographic Region

• Asia
• Europe
• North America
• ROW

With a complete study of the growth opportunities for companies, it has been identified that Asia will account for the highest share of the parasitic diseases therapeutics market throughout the forecast period. The rising prevalence of parasitic diseases and the increased funding and initiatives to control and prevent parasitic diseases are some of the factors fueling the growth of the parasitic diseases therapeutics market in this region.

Key Highlights of the Global Parasitic Diseases Therapeutics Market Report for the Forecast Period 2019-2023

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the parasitic diseases therapeutics market during the next five years
• Precise estimation of the global parasitic diseases therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the parasitic diseases therapeutics industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of parasitic diseases therapeutics companies

We can help! Our analysts can customize the parasitic diseases therapeutics​ market research report to meet your requirements. Get in touch